Brief: Amoeba Operating Loss At December, 31 Widens To 6.2 Million Euros

Amoeba SA

26/03/2021 07:25

March 26 (Reuters) - Amoeba SA  ALMIB.PA :
    * ANNOUNCES 2020 FINANCIAL YEAR RESULTS MARKED BY CONTINUED
DEVELOPMENT OF ITS BIOCIDAL AND BIOCONTROL APPLICATIONS
    * AT 31 DECEMBER 2020, AMOÉBA'S OPERATING LOSS WAS -€ 6,156K
COMPARED TO LOSS  - € 5,506K AT 31 DECEMBER 2019
    * AT 31 DECEMBER 2020, RESEARCH AND DEVELOPMENT EXPENSES
AMOUNTED
TO €1,612K, DOWN COMPARED TO 2019
    * AT 31 DECEMBER 2020, NET LOSS AMOUNTS TO -€8,157K COMPARED
TO
LOSS -€7,250K AT 31 DECEMBER 2019.
    * COMPANY'S CASH POSITION AT 31 DECEMBER 2020 WAS €4,975K
    * COVID-19 CRISIS THEREFORE HAD LITTLE IMPACT ON INCOME
STATEMENT
    * COMPANY HAS SUFFICIENT NET WORKING CAPITAL TO MEET ITS
OBLIGATIONS AND CASH REQUIREMENTS OVER THE NEXT TWELVE MONTHS

Source text for Eikon: [ID:https://bit.ly/3spHao2]
Further company coverage:  ALMIB.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))